Agentix
Biotechnology
· Dana Point, California, United States
· Est. 2013
· 1 open positions
Agentix Corp. (OTC: AGTX) is a clinical-stage biotechnology company developing novel biopharmaceuticals targeting the endocannabinoid system for metabolic diseases including Type 2 Diabetes, obesity, NAFLD, and NASH. It has licensed synthetic agonists, inverse agonists, and antagonists like AGTX-2003 and AGTX-2004 from partners such as NHRI and RTI International, advancing them toward clinical trials.
https://agentixcorp.com
← All companies